Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genes Identified that Control Vitamin B12 Metabolism

By Biotechdaily staff writers
Posted on 31 Dec 2002
Researchers have identified genes that underlie two severe diseases of vitamin B12 metabolism, the cblA and cblB forms of methylmalonic aciduria, which may cause brain damage, mental retardation and even death if not detected in infancy or early childhood. More...
Their findings were published in the November 26, 2002, issue of the Proceedings of the National Academy of Sciences.

Investigators from the University of Calgary (Canada) identified the vitamin B12 genes in bacteria, and then found their counterparts in humans by utilizing data available through the human genome project. Confirmation of the role of these genes in vitamin B12 metabolism was obtained through collaboration with the diagnostic facility and cell bank for genetic).

"We have identified two different genes that are critical to the processing of vitamin B12 by finding mutations in patients who have particular forms of methylmalonic aciduria,” explained first author Melissa Dobson of the University of Calgary. "Methylmalonic acid is a chemical intermediate in the breakdown of proteins and other substances. It accumulates in the body and is excreted in large amounts in the urine because the blocks in the processing of vitamin B12 prevent its metabolism.”





Related Links:
University of Calgary
McGill University

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Urine Analyzer
respons® UDS100
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: An elevated neutrophil-to-lymphocyte ratio (NLR), a rato easily obtained from a routine blood count, was associated with both short- and long-term Alzheimer’s risk (photo credit: 123RF)

Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

Alzheimer’s disease and related dementias develop over years, making it difficult to identify at-risk patients before symptoms appear. Clinicians therefore need widely available laboratory markers that... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.